MRNS: Marinus Pharmaceuticals, Inc. Company Short-Term Debt
The development of rare anticonvulsants is not subject to market cycles or seasonality, ensuring high business resilience. However, Marinus Pharmaceuticals (MRNS) is currently fighting for survival due to failures in tests of its lead drug, as confirmed by the price action chart on GURU.Markets, where the metric stands at 0.00. In this scientific race for leadership in neurology, the company is threatened by cheap generics and gene technologies.
Analytical breakdowns for Marinus Pharma (MRNS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Marinus Pharmaceuticals|MRNS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Marinus Pharmaceuticals|MRNS - Company Total Debt Obligations|Debt to Book Capitalization Ratio Marinus Pharmaceuticals, Inc.|MRNS - Company Long-Term Indebtedness|Company Current Liabilities Marinus Pharmaceuticals|Quick Liquidity marinuspharma.com
- earnings and multiples data:
Fundamental company analysis:MRNS - Marinus Pharmaceuticals, Inc.
The strong pricing power of Marinus Pharmaceuticals (MRNS) in the orphan drug segment may be offset by delays in insurance reimbursements; therefore, changes in the amount of short-term loans reflect the company's current liquidity needs for operational business maintenance. This metric aggregates all liabilities with a maturity of up to one year, allowing investors to assess refinancing risk and the actual balance sheet stability of the issuer in the face of short-term debt payments.
Direct competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|Company Current Liabilities xenon-pharma.com (XENE)|Company Short-Term Debts VKTX|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Company Short-Term Loans and Borrowings DNLI|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt Volume biohavenpharma.com BHVN|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Company Short-Term Indebtedness TRVI|Company Current Liabilities PRAX|Company Short-Term Debts Anavex Life Sciences Corp|Company Short-Term Debt CeriBell, Inc. (CBLL)|Short-Term Debt Volume Prothena Corporation plc|Alector - Company Current Liabilities|Company Short-Term Loans and Borrowings ANNX|OMER - Company Short-Term Debt|Current Liabilities NGNE|ACIU: Company Short-Term Debts|voyagertherapeutics.com - Company Short-Term Loans and Borrowings|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts Scilex Holding|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|ACOG (alphacognition.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|IKT - Company Current Liabilities|Cassava Sciences - Company Short-Term Debts|ASRT - Company Short-Term Debts|COYA: Company Short-Term Debts|Company Current Liabilities Vistagen|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Short-Term Debt acumenpharm.com ABOS|Company Current Liabilities CRVO (CervoMed)|Company Short-Term Debts alteritytherapeutics.com (ATHE)|Clene - Company Current Liabilities|Amount of Current Liabilities PEPG (PepGen Inc)|Jupiter Neurosciences - Company Short-Term Debts|Short-Term Debt Volume relmada.com RLMD|ANVS: Company Short-Term Debts|Company Current Liabilities Grace Therapeutics|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|Company Short-Term Debts ANEW Medical, Inc.|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|Company Short-Term Debt RVPH (revivapharma.com)|Company Short-Term Debt MetaVia MTVA|Short-Term Debt Volume NeurAxis Inc. (NRXS)|HSDT - Company Short-Term Debt|Passage Bio, Inc. (PASG) - Company Current Liabilities|bionomics.com.au (NEUP) - Company Short-Term Debt|minervaneurosciences.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Athira Pharma|Company Short-Term Indebtedness ADXN (Addex Therapeutics Ltd.)|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|Short-Term Debt Volume cyclerion.com|Company Short-Term Debt Protagenic Therapeutics, Inc. PTIX|KTTA: Company Short-Term Indebtedness|Cortigent Medical - Company Short-Term Debts|Short-Term Debt Avenue Therapeutics Inc.|BCLI (Brainstorm Cell Therapeutics, Inc.) - Company Current Liabilities|Cara Therapeutics Inc (CARA) - Company Short-Term Debts|Company Short-Term Debt Chromocell Therapeutics|ELYM: Company Short-Term Loans and Borrowings|Company Short-Term Debt Intra-Cellular Therapies (ITCI)|LBPH - Short-Term Debt|Company Short-Term Debt NKGen NKGN|NRBO - Company Current Liabilities|Sage Therapeutics, Inc. - Company Short-Term Debts|SNPX - Company Short-Term Debts|Trevena (TRVN) - Company Short-Term Debt|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Cerevel Corp (CERE) - Short-Term Debt Volume